▶ 調査レポート

世界のトリクラベンダゾール市場2021年ー2031年:剤形別(錠剤、経口懸濁液)、動物種類別、流通チャネル別

• 英文タイトル:Triclabendazole Market (Dosage Form: Tablet and Oral Suspension; Animal Type: Cattle, Sheep, Goat, and Others; and Distribution Channel: Veterinary Hospitals, Veterinary Clinics, Pharmacies & Drug Stores, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Transparency Market Researchが調査・発行した産業分析レポートです。世界のトリクラベンダゾール市場2021年ー2031年:剤形別(錠剤、経口懸濁液)、動物種類別、流通チャネル別 / Triclabendazole Market (Dosage Form: Tablet and Oral Suspension; Animal Type: Cattle, Sheep, Goat, and Others; and Distribution Channel: Veterinary Hospitals, Veterinary Clinics, Pharmacies & Drug Stores, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031 / MRC2201A020資料のイメージです。• レポートコード:MRC2201A020
• 出版社/出版日:Transparency Market Research / 2022年1月15日
• レポート形態:英文、PDF、179ページ
• 納品方法:Eメール
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥857,660 (USD5,795)▷ お問い合わせ
  Multi User¥1,301,660 (USD8,795)▷ お問い合わせ
  Corporate License¥1,745,660 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Transparency Market Research社の本調査レポートは、世界の人工心肺装置市場を調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、剤形別(錠剤、経口懸濁液)分析、動物種類別分析、流通チャネル別分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)分析、競争状況などの項目を掲載しています。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場概要
・キーインサイト
・世界の人工心肺装置市場規模:剤形別(錠剤、経口懸濁液)
・世界の人工心肺装置市場規模:動物種類別
・世界の人工心肺装置市場規模:流通チャネル別
・世界の人工心肺装置市場規模:地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)
・競争状況

TMR’s report on the global triclabendazole market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides revenue of the global triclabendazole market for the period 2017–2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global triclabendazole market from 2021 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the triclabendazole market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global triclabendazole market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global triclabendazole market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global triclabendazole market.

The report delves into the competitive landscape of the global triclabendazole market. Key players operating in the global triclabendazole market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global triclabendazole market profiled in this report.

Key Questions Answered in Triclabendazole Market Report
What is the sales/revenue generated by triclabendazole across all regions during the forecast period?
What are the opportunities in the global triclabendazole market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2031?
Which segment is likely to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?

Triclabendazole Market – Research Objectives and Research Approach

The comprehensive report on the global triclabendazole market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global triclabendazole market in terms of dosage form, animal type, distribution channel, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global triclabendazole market.

Triclabendazole Market – Segmentation

TMR’s study on the global triclabendazole market includes information divided into four segments: dosage form, animal type, distribution channel, and region. Changing industry trends and other market dynamics associated with these segments of the global triclabendazole market are discussed in detail.

[Dosage Form]
Tablet
Oral Suspension

[Animal Type]
Cattle
Sheep
Goat
Others

[Distribution Channel]
Veterinary Hospitals
Veterinary Clinics
Pharmacies & Drug Stores
Others

[Region]
North America
Europe
Asia Pacific
Latin America
Middle East & Africa

レポート目次

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Triclabendazole Market

4. Market Overview

4.1. Introduction

4.1.1. Market Definition

4.1.2. Industry Evolution / Developments

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Triclabendazole Market Analysis and Forecast, 2017–2031

4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

5.1. Prevalence rate of Fasciola hepatica in animal health

5.2. Sales Volume of Triclabendazole (Best effort Basis)

5.3. Pricing Analysis

5.4. Regulatory Scenario by Region/globally

5.5. COVID-19 Impact Analysis

6. Global Triclabendazole Market Analysis and Forecast, by Dosage Form

6.1. Introduction & Definition

6.1.1. Key Findings / Developments

6.2. Global Triclabendazole Market Value Forecast, by Dosage Form, 2017–2031

6.2.1. Tablet

6.2.2. Oral Suspension

6.3. Global Triclabendazole Market Attractiveness, by Dosage Form

7. Global Triclabendazole Market Analysis and Forecast, by Animal Type

7.1. Introduction & Definition

7.1.1. Key Findings / Developments

7.2. Global Triclabendazole Market Value Forecast, by Animal Type, 2017–2031

7.2.1. Cattle

7.2.2. Sheep

7.2.3. Goat

7.2.4. Others

7.3. Global Triclabendazole Market Attractiveness, by Animal Type

8. Global Triclabendazole Market Analysis and Forecast, by Distribution Channel

8.1. Introduction & Definition

8.1.1. Key Findings / Developments

8.2. Global Triclabendazole Market Value Forecast, by Distribution Channel, 2017–2031

8.2.1. Veterinary Hospitals

8.2.2. Veterinary Clinics

8.2.3. Pharmacies & Drug Stores

8.2.4. Others

8.3. Global Triclabendazole Market Attractiveness, by Distribution Channel

9. Global Triclabendazole Market Analysis and Forecast, by Region

9.1. Key Findings

9.2. Global Triclabendazole Market Value Forecast, by Region

9.2.1. North America

9.2.2. Europe

9.2.3. Asia Pacific

9.2.4. Latin America

9.2.5. Middle East & Africa

9.3. North America Triclabendazole Market Attractiveness, by Region

10. North America Triclabendazole Market Analysis and Forecast

10.1. Introduction

10.1.1. Key Findings

10.2. North America Triclabendazole Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031

10.2.1. Tablet

10.2.2. Oral Suspension

10.3. North America Triclabendazole Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031

10.3.1. Cattle

10.3.2. Sheep

10.3.3. Goat

10.3.4. Others

10.4. North America Triclabendazole Market Value Forecast, by Distribution Channel, 2017–2031

10.4.1. Veterinary Hospitals

10.4.2. Veterinary Clinics

10.4.3. Pharmacies & Drug Stores

10.4.4. Others

10.4.5. North America Triclabendazole Market Attractiveness, by Distribution Channel

10.5. North America Triclabendazole Market Value (US$ Mn) Forecast, by Country, 2017–2031

10.5.1. U.S.

10.5.2. Canada

10.6. North America Triclabendazole Market Attractiveness Analysis

10.6.1. By Dosage Form

10.6.2. By Animal Type

10.6.3. By Distribution Channel

10.6.4. By Country

11. Europe Triclabendazole Market Analysis and Forecast

11.1. Introduction

11.1.1. Key Findings

11.2. Europe Triclabendazole Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031

11.2.1. Tablet

11.2.2. Oral Suspension

11.3. Europe Triclabendazole Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031

11.3.1. Cattle

11.3.2. Sheep

11.3.3. Goat

11.3.4. Others

11.4. Europe Triclabendazole Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

11.4.1. Germany

11.4.2. U.K.

11.4.3. France

11.4.4. Spain

11.4.5. Italy

11.4.6. Rest of Europe

11.5. Europe Triclabendazole Market Attractiveness Analysis

11.5.1. By Dosage Form

11.5.2. By Animal Type

11.5.3. By Distribution Channel

11.5.4. By Country/Sub-region

12. Asia Pacific Triclabendazole Market Analysis and Forecast

12.1. Introduction

12.1.1. Key Findings

12.2. Asia Pacific Triclabendazole Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031

12.2.1. Tablet

12.2.2. Oral Suspension

12.3. Asia Pacific Triclabendazole Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031

12.3.1. Cattle

12.3.2. Sheep

12.3.3. Goat

12.3.4. Others

12.4. Asia Pacific Triclabendazole Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

12.4.1. China

12.4.2. Japan

12.4.3. India

12.4.4. Australia & New Zealand

12.4.5. Rest of Asia Pacific

12.5. Asia Pacific Triclabendazole Market Attractiveness Analysis

12.5.1. By Dosage Form

12.5.2. By Animal Type

12.5.3. By Distribution Channel

12.5.4. By Country/Sub-region

13. Latin America Triclabendazole Market Analysis and Forecast

13.1. Introduction

13.1.1. Key Findings

13.2. Latin America Triclabendazole Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031

13.2.1. Tablet

13.2.2. Oral Suspension

13.3. Latin America Triclabendazole Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031

13.3.1. Cattle

13.3.2. Sheep

13.3.3. Goat

13.3.4. Others

13.4. Latin America Triclabendazole Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

13.4.1. Brazil

13.4.2. Mexico

13.4.3. Rest of Latin America Latin America

13.5. Latin America Triclabendazole Market Attractiveness Analysis

13.5.1. By Dosage Form

13.5.2. By Animal Type

13.5.3. By Distribution Channel

13.5.4. By Country/Sub-region

14. Middle East & Africa Triclabendazole Market Analysis and Forecast

14.1. Introduction

14.1.1. Key Findings

14.2. Middle East & Africa Triclabendazole Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031

14.2.1. Tablet

14.2.2. Oral Suspension

14.3. Middle East & Africa Triclabendazole Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031

14.3.1. Cattle

14.3.2. Sheep

14.3.3. Goat

14.3.4. Others

14.4. Middle East & Africa Triclabendazole Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

14.4.1. GCC Countries

14.4.2. South Africa

14.4.3. Rest of Middle East & Africa

14.5. Middle East & Africa Triclabendazole Market Attractiveness Analysis

14.5.1. By Dosage Form

14.5.2. By Animal Type

14.5.3. By Distribution Channel

14.5.4. By Country/Sub-region

15. Competition Landscape

15.1. Market Player – Competition Matrix (by Tier and Size of companies)

15.2. Market Share / Position Analysis, by Company, 2020

15.3. Competitive Business Strategies

15.4. Company Profiles

15.4.1. AdvaCare Pharma

15.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)

15.4.1.2. Financial Analysis

15.4.1.3. Growth Strategies

15.4.1.4. SWOT Analysis

15.4.2. RV Lifesciences Limited

15.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)

15.4.2.2. Financial Analysis

15.4.2.3. Growth Strategies

15.4.2.4. SWOT Analysis

15.4.3. Grampus Laboratories

15.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)

15.4.3.2. Financial Analysis

15.4.3.3. Growth Strategies

15.4.3.4. SWOT Analysis

15.4.4. Intas Pharmaceuticals Ltd

15.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)

15.4.4.2. Financial Analysis

15.4.4.3. Growth Strategies

15.4.4.4. SWOT Analysis

15.4.5. Shanghai Tongren Pharmaceutical Co., Ltd.

15.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)

15.4.5.2. Financial Analysis

15.4.5.3. Growth Strategies

15.4.5.4. SWOT Analysis

15.4.6. Shijiazhuang Shimu Animal Pharmaceutical Co., Ltd.

15.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)

15.4.6.2. Financial Analysis

15.4.6.3. Growth Strategies

15.4.6.4. SWOT Analysis

15.4.7. Siflon Drugs & Pharmaceuticals Pvt. Ltd.

15.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)

15.4.7.2. Financial Analysis

15.4.7.3. Growth Strategies

15.4.7.4. SWOT Analysis

15.4.8. Elanco

15.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)

15.4.8.2. Financial Analysis

15.4.8.3. Growth Strategies

15.4.8.4. SWOT Analysis

15.4.9. Virbac

15.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)

15.4.9.2. Financial Analysis

15.4.9.3. Growth Strategies

15.4.9.4. SWOT Analysis

15.4.10. Bimeda, Inc.

15.4.10.1. Company Overview (HQ, Business Segments, Employee Strength)

15.4.10.2. Financial Analysis

15.4.10.3. Growth Strategies

15.4.10.4. SWOT Analysis

15.4.11. Chanelle Pharma

15.4.11.1. Company Overview (HQ, Business Segments, Employee Strength)

15.4.11.2. Financial Analysis

15.4.11.3. Growth Strategies

15.4.11.4. SWOT Analysis

15.4.12. Zoetis Health

15.4.12.1. Company Overview (HQ, Business Segments, Employee Strength)

15.4.12.2. Financial Analysis

15.4.12.3. Growth Strategies

15.4.12.4. SWOT Analysis

List of Tables

Table 01: Global Triclabendazole Market Volume (000 Unit) Forecast, by Oral Suspension, 2017–2031

Table 02: Global Triclabendazole Market Volume (000 Unit) Forecast, by Tablet, 2017–2031

Table 03: Global Triclabendazole Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031

Table 04: Global Triclabendazole Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031

Table 05: Global Triclabendazole Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 06: Global Triclabendazole Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 07: North America Triclabendazole Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 08: North America Triclabendazole Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031

Table 09: North America Triclabendazole Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031

Table 10: North America Triclabendazole Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 11: Europe Triclabendazole Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 12: Europe Triclabendazole Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031

Table 13: Europe Triclabendazole Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031

Table 14: Europe Triclabendazole Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 15: Asia Pacific Triclabendazole Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 16: Asia Pacific Triclabendazole Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031

Table 17: Asia Pacific Triclabendazole Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031

Table 18: Asia Pacific Triclabendazole Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 19: Latin America Triclabendazole Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 20: Latin America Triclabendazole Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031

Table 21: Latin America Triclabendazole Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031

Table 22: Latin America Triclabendazole Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 23: Middle East & Africa Triclabendazole Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 24: Middle East & Africa Triclabendazole Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031

Table 25: Middle East & Africa Triclabendazole Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031

Table 26: Middle East & Africa Triclabendazole Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031